Quantbot Technologies LP Ultragenyx Pharmaceutical Inc. Transaction History

Quantbot Technologies LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$33.72 - $46.33 $210,244 - $288,867	6,235 New	6,235 $288,000
Q3 2021 Nov 09, 2021	SELL	$77.92 - $102.4 $323,212 - $424,755	-4,148 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$92.19 - $115.71 $82,786 - $103,907	-898 Reduced 17.8%	4,148 $395,000
Q1 2021 May 14, 2021	BUY	$106.9 - $167.73 $509,913 - $800,072	4,770 Added 1728.26%	5,046 $574,000
Q4 2020 Feb 12, 2021	SELL	$84.4 - $177.39 $94,528 - $198,676	-1,120 Reduced 80.23%	276 $38,000
Q3 2020 Nov 16, 2020	BUY	$72.98 - $90.0 $101,880 - $125,640	1,396 New	1,396 $114,000
Q1 2020 May 13, 2020	SELL	$33.8 - $62.9 $90,347 - $168,131	-2,673 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$36.08 - $45.83 $96,441 - $122,503	2,673 New	2,673 $114,000
Q3 2019 Nov 12, 2019	SELL	$42.5 - $63.11 $4,250 - $6,311	-100 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$54.93 - $74.36 $5,493 - $7,436	100 New	100 $6,000

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.